"Safety" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property.
| Descriptor ID |
D012449
|
| MeSH Number(s) |
N06.850.135.060.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Safety".
Below are MeSH descriptors whose meaning is more specific than "Safety".
This graph shows the total number of publications written about "Safety" by people in this website by year, and whether "Safety" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2011 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 6 | 6 |
| 2017 | 6 | 18 | 24 |
| 2018 | 10 | 21 | 31 |
| 2019 | 2 | 8 | 10 |
| 2020 | 9 | 41 | 50 |
| 2021 | 4 | 18 | 22 |
To return to the timeline, click here.
Below are the most recent publications written about "Safety" by people in Profiles.
-
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 12 01; 6(12):1451-1460.
-
Medicines management at home during the COVID-19 pandemic: a qualitative study exploring the UK patient/carer perspective. Int J Pharm Pract. 2021 Oct 18; 29(5):458-464.
-
A Broader View of Risk to Health Care Workers: Perspectives on Supporting Vulnerable Health Care Professional Households During COVID-19. Acad Med. 2021 09 01; 96(9):1233-1235.
-
Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia. Br J Haematol. 2021 12; 195(5):703-705.
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
-
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 06; 70(31):1053-1058.
-
Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients. Br J Haematol. 2021 11; 195(4):523-531.
-
Coronavirus disease 2019 and flight safety. Anatol J Cardiol. 2021 08; 25(Suppl 1):34-35.
-
Firms' challenges and social responsibilities during Covid-19: A Twitter analysis. PLoS One. 2021; 16(7):e0254748.
-
COVID-19 Awareness and Preparedness of Minnesota and Wisconsin Dairy Farms. J Agromedicine. 2021 07; 26(3):352-359.